Delivery Order SPE2DB24D3013-SPE2DB25FFNHA

Award Date 7/12/25
Potential Completion Date 7/14/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ESOMEPRAZOLE MAG DR 20 MG CAP 90S. The firm-fixed-price contract has a ceiling value of $1,710.14 and a completion date of June 17, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ESOMEPRAZOLE MAG DR 20 MG CAP 90S. The award has a ceiling value of $1,411.61 and a completion date of July 2, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency, and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,030.56, is a Firm Fixed Price Delivery Order for the supply of ESOMEPRAZOLE MAG DR 40 MG CAP 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award, SPE2DB20D1004|SPE2DB22FF5V7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The $1,360.78 firm-fixed-price delivery order is for the supply of 4557045057 - ESOMEPRAZOLE MAG DR 20 MG CAP 30S. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,593.73, is for the delivery of Esomeprazole 40mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed price delivery order for the supply of 4,564,258,862 units of esomeprazole magnesium delayed-release 40 milligram capsules in 90-count packages. The total ceiling value of the contract is $5,715.44, with a period of performance extending...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Esomeprazole Magnesium delayed-release capsules, a medication used to treat acid reflux and other gastrointestinal conditions. The contract has a ceiling value of $1,599.00 and is a firm fixed-price delivery order, with a period of performance ending on May 22, 2025. The contract is not...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $6,828.05 firm-fixed-price contract is for the supply of 4,565,333,285 units of Esomeprazole Magnesium Delayed-Release 40 mg capsules. This appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Esomeprazole Magnesium Delayed-Release capsules. The $1,338.91 fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen will provide these prescription medications to support military treatment facilities and other government healthcare programs. This delivery order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.12, is for the delivery of esomeprazole magnesium delayed-release 40 mg capsules. This contract is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFNHA
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ESOMEPRAZOLE MAG DR 20 MG CAP 30S, a prescription medication, with a ceiling value of $3,289.69. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA, valued at $999,999,999.00. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract does not have a set-aside designation, indicating open competition. As a critical pharmaceutical supplier to federal agencies, AmerisourceBergen Drug Corp leverages its extensive capabilities to fulfill diverse medical product requirements for the U.S. government, particularly the Defense Health Agency, U.S. Coast Guard, and other government customers.

Generated 10/11/25, 9:48 AM